Acetyl--carnitine Administration Increases Insulin-like Growth Factor 1 Levels in Asymptomatic HIV-1-Infected Subjects: Correlation with Its Suppressive Effect on Lymphocyte Apoptosis and Ceramide Generation
- 31 July 1999
- journal article
- Published by Elsevier in Clinical Immunology
- Vol. 92 (1) , 103-110
- https://doi.org/10.1006/clim.1999.4727
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- HIV-1 infection and cellular metabolismImmunology Today, 1996
- Ceramide, AIDS and long-term survivorsImmunology Today, 1996
- L-Acetylcarnitine in the Treatment of Patients with Peripheral NeuropathiesClinical Drug Investigation, 1995
- The relevance of apoptosis to AIDS pathogenesisTrends in Cell Biology, 1995
- Apoptosis, anti-apoptotic compounds and TNF-α releaseImmunology Today, 1994
- Programmed Cell Death Induced by CeramideScience, 1993
- Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals.The Journal of Experimental Medicine, 1992
- A role for IGF-1 in the rescue of CNS neurons following hypoxic-ischemic injuryBiochemical and Biophysical Research Communications, 1992
- Growth and neuroendocrine dysfunction in children with acquired immunodeficiency syndromeThe Journal of Pediatrics, 1990
- Lymphocyte subset distribution and natural killer activity in growth hormone deficiency before and during short-term treatment with growth hormone releasing hormoneClinical Immunology and Immunopathology, 1988